ELAVL1 and colorectal carcinoma: On the basis of these pleiotropic functions in tumor development and progression, inhibition of HuR either alone or in combination with established therapeutic approaches offers an attractive novel strategy for treatment of some common human cancers including colorectal carcinoma.